Reference health

Pharmacogenomics and Efficacy of Risperidone Long‐Term Treatment in Thai Autistic Children and Adolescents

https://doi.org/10.1111/bcpt.12803
CiteStamped reference-health badge
34/34 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

5 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 34 checked references that resolve
resolves10.1097/HRP.0000000000000030
Psychopharmacological Interventions in Autism Spectrum Disorder
resolves10.1089/cap.2012.0058
An Open-Label Extension Study of the Safety and Efficacy of Risperidone in Children and Adolescents with Autistic Disorder
resolves10.4103/0253-7176.127254
Effects of Risperidone on Core Symptoms of Autistic Disorder Based on Childhood Autism Rating Scale: An Open Label Study
resolves10.1089/104454604773840472
Risperidone Treatment of Children with Autistic Disorder: Effectiveness, Tolerability, and Pharmacokinetic Implications
resolves10.1177/0091270009347867
Effect of CYP2D6, CYP3A5, and MDR1 Genetic Polymorphisms on the Pharmacokinetics of Risperidone and Its Active Moiety
resolves10.1097/JCP.0b013e3181a289e0
Effects of CYP2D6 and CYP3A5 Genotypes on the Plasma Concentrations of Risperidone and 9-Hydroxyrisperidone in Korean Schizophrenic Patients
resolves10.1097/JCP.0b013e31828ecd52
Impact of the ABCB1 Gene Polymorphism on Plasma 9-Hydroxyrisperidone and Active Moiety Levels in Japanese Patients With Schizophrenia
resolves10.1007/s00228-010-0850-1
The role of CYP2D6 and ABCB1 pharmacogenetics in drug-naïve patients with first-episode schizophrenia treated with risperidone
resolves10.1111/dmcn.12470
<scp>CYP</scp>2D6 genotyping in paediatric patients with autism treated with risperidone: a preliminary cohort study
resolves10.1038/tpj.2009.63
Pharmacogenetics of risperidone therapy in autism: association analysis of eight candidate genes with drug efficacy and adverse drug reactions
resolves10.1016/j.dmpk.2016.01.005
Detection of CYP2D6 polymorphism using Luminex xTAG technology in autism spectrum disorder: CYP2D6 activity score and its association with risperidone levels
resolves10.1002/jcla.22009
Development and Validation of Liquid Chromatography/Tandem Mass Spectrometry Analysis for Therapeutic Drug Monitoring of Risperidone and 9‐Hydroxyrisperidone in Pediatric Patients with Autism Spectrum Disorders
resolves10.1089/cap.2000.10.79
Long-Term Risperidone for Pervasive Developmental Disorder: Efficacy, Tolerability, and Discontinuation
resolves10.1097/00004583-200202000-00007
Risperidone Treatment in Children and Adolescents With Autism: Short- and Long-Term Safety and Effectiveness
resolves10.1016/0893-133X(94)00129-N
Radioreceptor Binding Profile of the Atypical Antipsychotic Olanzapine
resolves10.1038/sj.mp.4000350
The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers
resolves10.1038/sj.mp.4000343
D2 receptors binding potential is not affected by Taq1 polymorphism at the D2 receptor gene
resolves10.1097/JCP.0b013e31822c09a7
Comparing the Influence of Dopamine D2 Polymorphisms and Plasma Drug Concentrations on the Clinical Response to Risperidone
resolves10.1016/j.psychres.2016.04.001
Relation between serum prolactin levels and antipsychotic response to risperidone in patients with schizophrenia
resolves10.1097/JCP.0000000000000474
Impact of Pharmacogenetic Markers of CYP2D6 and DRD2 on Prolactin Response in Risperidone-Treated Thai Children and Adolescents With Autism Spectrum Disorders
resolves10.1097/FTD.0b013e3181858ca9
ABCB1 Polymorphisms Influence Steady-State Plasma Levels of 9-Hydroxyrisperidone and Risperidone Active Moiety
resolves10.2217/14622416.7.7.987
Polymorphisms of the<i>ABCB1</i>Gene are Associated with the Therapeutic Response to Risperidone in Chinese Schizophrenia Patients
resolves10.1097/00004850-200503000-00002
Prediction of response to risperidone treatment with respect to plasma concencentrations of risperidone, catecholamine metabolites, and polymorphism of cytochrome P450 2D6
resolves10.1007/s40268-015-0092-x
Comparative Pharmacology of Risperidone and Paliperidone
resolves10.1111/bph.12295
Signalling profile differences: paliperidone versus risperidone
resolves10.1124/jpet.111.189076
Relationship between Dose, Drug Levels, and D2 Receptor Occupancy for the Atypical Antipsychotics Risperidone and Paliperidone
resolves10.1016/j.biopsych.2004.06.020
The –1438A/G polymorphism in the 5-hydroxytryptamine type 2A receptor gene affects promoter activity
resolves10.1093/hmg/6.4.577
A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia
resolves10.1073/pnas.0508189103
A functional variant of the dopamine D <sub>3</sub> receptor is associated with risk and age-at-onset of essential tremor
resolves10.1089/cap.2015.0005
Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial
resolves10.1159/000287535
Depression, Hostility and Anxiety in Hyperprolactinemic Amenorrhea
resolves10.1176/ajp.141.6.759
Hyperprolactinemia, distress, and hostility
resolves10.1016/j.ijlp.2009.06.001
Understanding human aggression: New insights from neuroscience
resolves10.14205/2312-3710.2014.01.01.3
Mechanisms of Increased Appetite and Weight Gain Induced by Psychotropic Medications
The 5 references without a DOI — listed, not checked
no DOI — not checkedAutism: Recognition, Referral and Diagnosis of Children and Young People on the Autism Spectrum
no DOI — not checkedGoodman and Gilman's The Pharmacological Basis of Therapeutics
no DOI — not checkedMDR1 (ABCB1) polymorphisms: functional effects and clinical implications
no DOI — not checkedHyperprolactinemia in Thai children and adolescents with autism spectrum disorder treated with risperidone
no DOI — not checkedStudies on the neuroendocrine role of serotonin
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1111/bcpt.12803"><img src="https://citestamp.com/citestamped/10.1111/bcpt.12803/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1111/bcpt.12803/badge.svg)](https://citestamp.com/citestamped/10.1111/bcpt.12803)